SCHEMBL8274205

SCHEMBL8274205

COc1cc(C(F)(F)F)nc2nc(C)ccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.55
KMT2A Q03164 4/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 1/20 0.46
KDM4E B2RXH2 4/20 0.42
PDE4B Q07343 2/20 0.41
CYP1A2 P05177 1/20 0.41
GAA P10253 3/20 0.40
MAPT P10636 2/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 4/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
HTT P42858 4/20 0.37
NR2F2 P24468 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
HSD17B10 Q99714 2/20 0.37
HPGD P15428 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13409560 0.84 ALDH1A1 (0.39) ADORA1KMT2AALDH1A1MEN1KDM4E
SCHEMBL1536291 0.79 ADORA1 (0.54) ADORA1KMT2AALDH1A1MEN1KDM4E
SCHEMBL8273101 0.78 ALDH1A1 (0.44) ADORA1KMT2AALDH1A1MEN1KDM4E
SCHEMBL3968912 0.71 HPGD (0.57) ADORA1KMT2AALDH1A1MEN1KDM4E
SCHEMBL8274224 0.71 ADORA1 (1.00) ADORA1KMT2AALDH1A1MEN1KDM4E
SCHEMBL3952773 0.70 TNKS (0.47) KMT2AALDH1A1MEN1KDM4EPDE4B
SCHEMBL28316951 0.69 CCR1 (0.39) KDM4EPDE4BCYP1A2RAB9AHSP90AA1
SCHEMBL28510373 0.68 NT5E (0.63) KMT2AALDH1A1MEN1KDM4EMAPT
SCHEMBL28000913 0.67 KDM4E (0.43) ADORA1KDM4EPDE4BCYP1A2GAA
SCHEMBL3208142 0.67 SMPD3 (0.41) KMT2AALDH1A1MEN1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863793-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-07-04 EP disclosed
US-7705146-B2 Hepatitis C inhibitor peptide analogs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-27 US disclosed
WO-2006000085-A1 HEPATITIS C INHIBITOR PEPTIDE ANALOGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-01-05 WO disclosed